All Stories

  1. Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5

    Article • Proceedings of the National Academy of Sciences, September 2022, Proceedings of the National Academy of Sciences

    Markus Kipp